{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:15:54Z","timestamp":1760886954992},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5479,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1046\/j.1523-1747.2000.00158.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:56:15Z","timestamp":1047448575000},"page":"935-941","source":"Crossref","is-referenced-by-count":37,"title":["Anti-Inflammatory Drugs Block Cytokine mRNA Accumulation in the Skin and Improve the Clinical Condition of Reactional Leprosy Patients"],"prefix":"10.1016","volume":"115","author":[{"given":"Milton O.","family":"Moraes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euzenir N.","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane M.B.","family":"Teles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre S.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno C.C.","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.C.","family":"Nery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth P.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0010","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.4049\/jimmunol.158.12.5589","article-title":"Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes","volume":"158","author":"Blotta","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0015","first-page":"192","article-title":"Pentoxifylline suppression of tumor necrosis factor gene transcription","volume":"110","author":"Doherty","year":"1991","journal-title":"Surgery"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.173.1.25","article-title":"Differentiation of T cell lymphokine gene expression: in vitro acquisition of T cell memory","volume":"173","author":"Ehlers","year":"1991","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0025","first-page":"2834","article-title":"Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor","volume":"84","author":"Franchimont","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2169\/internalmedicine.38.717","article-title":"Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"38","author":"Fujimoto","year":"1999","journal-title":"Intern Med"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0162-3109(95)00050-X","article-title":"Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade","volume":"31","author":"Geitz","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-3083.1999.00538.x","article-title":"Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood","volume":"49","author":"Hodge","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0045","first-page":"316","article-title":"Thalidomide in type-2 lepra reaction: a clinical experience","volume":"62","author":"Jadhav","year":"1990","journal-title":"Indian J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0050","first-page":"421","article-title":"Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock","volume":"278","author":"Jilg","year":"1996","journal-title":"Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0055","first-page":"45","article-title":"Imunobiology of leprosy","volume":"28","author":"Kaplan","year":"1986","journal-title":"Int Rev Exp Pathol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2249.1995.tb05532.x","article-title":"Tumor necrosis factor-alpha (TNF\u03b1 synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions","volume":"99","author":"Khanolkar-Young","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00024382-199801000-00002","article-title":"Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline","volume":"9","author":"Kleinschmidt","year":"1998","journal-title":"Shock"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0075","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.159.10.5157","article-title":"Inhibition of interleukin-12 production by thalidomide","volume":"159","author":"Moller","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2567.1997.00246.x","article-title":"Inhibition of human interleukin-12 production by pentoxifylline","volume":"91","author":"Moller","year":"1997","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-3083.1999.00622.x","article-title":"Cytokine mRNA expression in leprosy reaction: a possible role for IFN\u03b3 and IL-12 in reactions (RR and ENL)","volume":"50","author":"Moraes","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0090","first-page":"61","article-title":"Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL","volume":"66","author":"Moreira","year":"1998","journal-title":"Int J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0095","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor \u03b1 by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.44.2.186","article-title":"Anti-inflammatory drugs and endothelial cell adhesion molecule expression in murine vascular beds","volume":"44","author":"Mori","year":"1999","journal-title":"Gut"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0105","first-page":"S21","article-title":"Treatment of reactions and nerve damage","volume":"64","author":"Naafs","year":"1996","journal-title":"Int J Lepr Supplement"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1523-1747.1999.00744.x","article-title":"Thalidomide increases human keratinocyte migration and proliferation","volume":"113","author":"Nasca","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0115","series-title":"Ind J Lepr","article-title":"The use of pentoxifylline in the treatment of type II reactional episodes","author":"Nery","year":"1999"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","article-title":"Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes","volume":"90","author":"Neuner","year":"1997","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02505228","article-title":"Cytokine expression in psoriatic skin lesions during PUVA therapy","volume":"288","author":"Olaniran","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0130","first-page":"293","article-title":"The use of corticosteroids in leprosy","volume":"52","author":"Pearson","year":"1981","journal-title":"Lepr Rev"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/7.4.517","article-title":"Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs","volume":"7","author":"Platzer","year":"1995","journal-title":"Int Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0140","first-page":"316","article-title":"Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum","volume":"66","author":"Rea","year":"1998","journal-title":"Int J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0145","first-page":"255","article-title":"Classification of leprosy according to immunity\u2013-a five group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0150","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/eji.1830230802","article-title":"Phosphodiestarase inhibitor pentoxifylline, a selective suppressor of T helper type-1 but not type-2 associated lymphokine production, prevents induction of experimental autoimmune encephalo- myelitis in Lewis rats","volume":"23","author":"Rott","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0162-3109(98)00010-1","article-title":"Differential regulation by Thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells","volume":"40","author":"Rowland","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2249.1998.00510.x","article-title":"Pentoxifylline decreases in vivo and in vitro tumor necrosis factor-\u03b1 (TNF\u03b1) production in lepromatous leprosy patients with erythema nodosum leprosum","volume":"111","author":"Sampaio","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0170","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor-\u03b1 production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0175","first-page":"103","article-title":"Serum levels of tumor necrosis factor-alpha and interleukin 1\u03b2 during leprosy reactional states","volume":"84","author":"Sarno","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0180","first-page":"570","article-title":"Is pentoxifylline a viable alternative in the treatment of ENL?","volume":"63","author":"Sarno","year":"1995","journal-title":"Int J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0185","first-page":"S69","article-title":"Role of inflammatory cytokines in tissue injury in leprosy","volume":"64","author":"Sarno","year":"1996","journal-title":"Int J Lepr"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0190","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/BF01844196","article-title":"An overview of glucocorticoid anti-inflammatory actions","volume":"45","author":"Schleimer","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1980.tb00342.x","article-title":"The treatment of lepra reaction in lepromatous leprosy: fifteen years' experience with thalidomide","volume":"19","author":"Sheskin","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0200","first-page":"357","article-title":"Lepromatous leprosy patients show T helper 1-like profile with differential expression of interleukin-10 during type 1 and 2 reactions","volume":"76","author":"Sreenivasan","year":"1998","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0205","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2567.1996.500561.x","article-title":"Differential regulation of tumor necrosis factor-\u03b1 mRNA degradation in macrophages by interleukin-4 and interferon-\u03b3","volume":"87","author":"Suk","year":"1996","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0210","first-page":"151","article-title":"Pentoxifylline a potent inhibitor of IL-2 and IFN\u03b3 biosynthesis and BCG-induced cytotoxicity","volume":"80","author":"ThanhauSeries","year":"1993","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2567.1998.00485.x","article-title":"Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy","volume":"94","author":"Trao","year":"1998","journal-title":"Immunology"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0225","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.4049\/jimmunol.159.9.4474","article-title":"Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in the lesional skin: a follow up study","volume":"159","author":"Verhagen","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0230","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4049\/jimmunol.153.2.811","article-title":"IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells","volume":"153","author":"Wang","year":"1994","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0235","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","article-title":"Interleukin (IL) -10 inhibits nuclear factor \u03baB (NF\u03baB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.1925582","article-title":"Defining protective responses to pathogens: cytokine profile in leprosy lesions","volume":"254","author":"Yamamura","year":"1991","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2000.00158.x_bb0245","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"Yamamura","year":"1992","journal-title":"J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15410632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15410632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:49:47Z","timestamp":1682102987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15410632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0022202X15410632"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00158.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}